Bertil Lindahl Selected Research

Cystatin C

9/2017	Quantification of Renal Function and Cardiovascular Mortality in Patients Admitted to the Emergency Department with Suspected Acute Coronary Syndromes.
2/2015	Relation between cardiovascular disease risk markers and brain infarcts detected by magnetic resonance imaging in an elderly population.
1/2013	GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in men.
7/2010	Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.
8/2008	Risk prediction in chest pain patients by biochemical markers including estimates of renal function.
10/2004	Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bertil Lindahl Research Topics

Disease

133	Myocardial Infarction 04/2024 - 01/2002
59	Acute Coronary Syndrome 03/2024 - 06/2002
35	Coronary Artery Disease (Coronary Atherosclerosis) 09/2023 - 05/2002
29	Heart Failure 11/2023 - 06/2002
28	Chest Pain (Chest Pains) 12/2023 - 08/2002
23	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 06/2003
19	Heart Diseases (Heart Disease) 12/2023 - 10/2010
18	ST Elevation Myocardial Infarction 10/2023 - 12/2003
13	Inflammation (Inflammations) 09/2023 - 12/2003
13	Necrosis 02/2022 - 01/2003
10	Stroke (Strokes) 11/2023 - 02/2015
10	MINOCA 01/2023 - 04/2017
9	Non-ST Elevated Myocardial Infarction 12/2021 - 10/2013
8	Infarction (Infarctions) 01/2021 - 02/2002
7	Atrial Fibrillation 01/2023 - 10/2007
6	Thrombosis (Thrombus) 04/2024 - 05/2003
6	Hemorrhage 11/2023 - 02/2015
5	Obesity 12/2023 - 07/2012
5	Myocardial Ischemia (Ischemic Heart Diseases) 11/2023 - 08/2005
5	Unstable Angina 12/2017 - 01/2002
4	Atherosclerosis 10/2021 - 09/2008
4	Hypoxia (Hypoxemia) 01/2021 - 01/2017
4	Hypertension (High Blood Pressure) 01/2020 - 08/2010
4	Ischemia 01/2016 - 07/2003
4	Diabetes Mellitus 01/2013 - 06/2002
3	Neoplasms (Cancer) 11/2023 - 01/2013
3	COVID-19 02/2022 - 12/2020
3	Ischemic Stroke 01/2021 - 12/2015
3	Left Ventricular Dysfunction 01/2019 - 08/2008
2	Chronic Obstructive Pulmonary Disease (COPD) 11/2023 - 12/2020
2	Pneumonia (Pneumonitis) 11/2023 - 05/2021
2	Pathologic Constriction (Stenosis) 01/2023 - 01/2018
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2020
2	Wounds and Injuries (Trauma) 12/2018 - 01/2018
2	Cardiogenic Shock 01/2018 - 01/2017
2	Aortic Dissection 02/2017 - 01/2017
2	Pulmonary Embolism 02/2017 - 10/2013
2	Coronary Disease (Coronary Heart Disease) 01/2013 - 05/2002
2	Reperfusion Injury 12/2007 - 02/2007

Drug/Important Bio-Agent (IBA)

70	TroponinIBA 12/2023 - 05/2002
59	Biomarkers (Surrogate Marker)IBA 04/2024 - 07/2003
55	Troponin T (Troponin T1)IBA 01/2024 - 05/2002
42	Troponin IIBA 10/2023 - 06/2003
22	trans-crotonin (CTN)IBA 09/2023 - 07/2012
22	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 08/2002
20	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 08/2002
14	Oxygen (Dioxygen)IBA 04/2024 - 01/2005
14	Dalteparin (Dalteparin Sodium)FDA Link 06/2012 - 05/2002
11	C-Reactive ProteinIBA 01/2023 - 03/2003
9	Growth Differentiation Factor 15IBA 01/2023 - 02/2007
7	Proteins (Proteins, Gene)FDA Link 02/2024 - 09/2015
6	omega-Chloroacetophenone (Mace)IBA 11/2023 - 01/2016
6	Natriuretic PeptidesIBA 05/2021 - 09/2004
6	Cystatin CIBA 09/2017 - 10/2004
5	LDL CholesterolIBA 12/2023 - 01/2014
5	Trinitrotoluene (TNT)IBA 02/2022 - 03/2003
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 12/2004
5	CreatinineIBA 01/2019 - 06/2002
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024 - 04/2017
4	oxidized low density lipoproteinIBA 12/2023 - 01/2014
4	TicagrelorIBA 11/2023 - 11/2020
4	MyoglobinIBA 12/2021 - 10/2004
4	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 02/2002
3	Fibrinolytic Agents (Antithrombotic Agents)IBA 04/2024 - 10/2004
3	Interleukin-6 (Interleukin 6)IBA 12/2021 - 12/2003
3	Angiotensin Receptor AntagonistsIBA 01/2021 - 04/2017
3	CytokinesIBA 01/2019 - 02/2007
3	GadoliniumIBA 01/2018 - 11/2015
3	fibrin fragment D (D-dimer)IBA 11/2017 - 02/2002
2	Clopidogrel (Plavix)FDA Link 11/2023 - 11/2020
2	Fibroblast Growth Factor-23IBA 12/2021 - 10/2021
2	LigandsIBA 10/2021 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 01/2005
2	ReninIBA 01/2021 - 01/2019
2	insulin receptor-related receptor (IRR)IBA 12/2020 - 01/2019
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2020 - 01/2020
2	DiureticsIBA 01/2020 - 02/2005
2	Peroxidase (Myeloperoxidase)IBA 01/2019 - 02/2010
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2019 - 12/2015
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2019 - 12/2015
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2019 - 05/2003
2	Adenosine Diphosphate (ADP)IBA 11/2018 - 01/2017
2	apixabanIBA 06/2017 - 02/2015
2	AdrenomedullinIBA 12/2015 - 10/2013
2	Indicators and Reagents (Reagents)IBA 10/2013 - 02/2004
2	Transforming Growth Factor beta (TGF-beta)IBA 12/2007 - 02/2007
2	MB Form Creatine KinaseIBA 08/2005 - 10/2004
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2003 - 05/2003
1	Metoprolol (Toprol-XL)FDA LinkGeneric 04/2024
1	Bisoprolol (Concor)FDA LinkGeneric 04/2024
1	Triglycerides (Triacylglycerol)IBA 02/2024

Therapy/Procedure

33	Therapeutics 12/2023 - 05/2004
11	Percutaneous Coronary Intervention 04/2024 - 12/2013
7	Secondary Prevention 01/2021 - 09/2009
6	Patient Readmission 01/2021 - 01/2016
2	Cardiac Rehabilitation 12/2023 - 01/2023
2	Length of Stay 10/2023 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2020 - 10/2013
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2019 - 08/2004
2	Stents 01/2018 - 02/2015